Yamatani Hide, Feit Marvin, Mann Aaron
a School of Social Work , University of Pittsburgh , Pittsburgh , Pennsylvania , USA.
b The Ethelyn R. Strong School of Social Work , Norfolk State University , Norfolk , Virginia , USA.
Soc Work Public Health. 2017;32(4):290-300. doi: 10.1080/19371918.2017.1282389. Epub 2017 Mar 7.
Although the basic paradigm of the U.S. federal drug policy targeting the supply and demand reduction has not changed since its enactment in 1970, there have been seriously undesirable disparate treatments and impacts among various population groups. Although U.S. Congress could not define what is discrimination, it did provide two major criteria for the assessment of discriminatory practices as follows: (a) disparate treatment-basing a key decision on association with any of the five prohibited individual's demographic classifications (race, color, religion, sex, or national origin); and (b) disparate impact-correlation between any of the five prohibited demographic classifications and the key outcomes. In reference to those criteria, this article describes evidence-based indicators of national failure of the Comprehensive Drug Abuse Prevention and Control Act.
尽管自1970年美国联邦毒品政策颁布以来,其针对减少供应和需求的基本范式未曾改变,但在不同人群之间却出现了严重不良的差别对待和影响。虽然美国国会无法界定何为歧视,但确实提供了评估歧视性做法的两个主要标准,如下所述:(a)差别对待——基于与五个被禁止的个人人口分类(种族、肤色、宗教、性别或国籍)中的任何一项的关联做出关键决策;(b)差别影响——五个被禁止的人口分类中的任何一项与关键结果之间的关联。参照这些标准,本文描述了《综合药物滥用预防与控制法案》在全国范围内失效的循证指标。